A composition comprising a compound of formula (Va) wherein n is 1 or 2 and wherein m is 1 or 2, with n and m preferably both being 1 or both being 2, more preferably both being 1, and/or, preferably and, a compound of formula, wherein n is 1 or 2 and wherein m is 1 or 2, with n and m preferably both being 1 or both being 2, more preferably both being 1, and wherein at least 90 weight-% of the composition consist of compounds of formula (Va) and formula (Vb).

##STR00001##

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene-9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the preparation of these anthraquinone derivatives.

A method of producing an anthraquinone-based substance represented by the following chemical formula:

##STR00001##

where at least one of R.sub.1 to R.sub.8 is a hydroxy group, and at least one of R.sub.1 to R.sub.8 is an alkoxy group, includes the steps of: preparing a starting material represented by the following chemical formula:

##STR00002##

where at least two of the R.sub.1 to R.sub.8 are hydroxy groups; and reacting the starting material with an organic alkylating agent. The amount of the organic alkylating agent to be reacted with the starting material is more than or equal to 0.05 mol and less than n mol per 1 mol of the starting material, where n is the number of hydroxy groups contained in the starting material.

A method of producing an anthraquinone-based substance represented by the following chemical formula:

##STR00001##

where at least one of R.sub.1 to R.sub.8 is a hydroxy group, and at least one of R.sub.1 to R.sub.8 is an alkoxy group, includes the steps of: preparing a starting material represented by the following chemical formula:

##STR00002##

where at least two of the R.sub.1 to R.sub.8 are hydroxy groups; and reacting the starting material with an organic alkylating agent. The amount of the organic alkylating agent to be reacted with the starting material is more than or equal to 0.05 mol and less than n mol per 1 mol of the starting material, where n is the number of hydroxy groups contained in the starting material.

The present invention provides a compound represented by the following formula (I): ##STR00001##
wherein each symbol is as described in the DESCRIPTION, which has a superior peripheral blood lymphocyte decreasing action, and is useful for the treatment or prophylaxis of autoimmune diseases; prophylaxis or suppression of resistance or acute rejection or chronic rejection of transplantation of organ or tissue; treatment or prophylaxis of graft-versus-host (GvH) disease due to bone marrow transplantation; or treatment or prophylaxis of allergic diseases.